Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(37 Publications)
Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) is a rabbit monoclonal antibody detecting RIP3 in Western Blot, Dot Blot. Suitable for Mouse.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications
View Alternative Names
Rip3, Ripk3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3, mRIP3
- WB
Supplier Data
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
Blocking and diluting buffer concentration : 5% NFDM/TBST.
ab181602 GAPDH was used as a loading control at 1/1000000 dilution.
We recommend involving downstream protein p-MLKL as a control to validate the stimulation of p-RIP3.
Lanes 1 - 4:
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) at 1/1000 dilution
Lanes 5 - 8:
Western blot - Anti-MLKL (phospho S345) antibody [EPR9515(2)] (<a href='/en-us/products/primary-antibodies/mlkl-phospho-s345-antibody-epr95152-ab196436'>ab196436</a>) at 1/1000 dilution
Lanes 1, 3, 5 and 7:
Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg
Lanes 2 and 6:
L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 8 hours whole cell lysate at 20 µg
Lanes 4 and 8:
L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 6 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa,54 kDa
Observed band size: 53 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
Blocking/Dilution buffer : 5% NFDM/TBST.
Cells were lysed in 4% SDS buffer (4% SDS,10% 2-ME, 20% glycerol, 0.004% Bromophenol blue, Tris-HCl).
The images were kindly provided by our collaborator Dr. Jiahuai Han, Xiamen University.
All lanes:
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) at 1/500 dilution
Lane 1:
Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg
Lane 2:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 10 ng/ml TNF-a and 20 µM z-VAD for 2 hours at 20 µg
Lane 3:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 10 ng/ml TNF-a and 20 µM z-VAD for 3.5 hours at 20 µg
Lane 4:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours at 20 µg
Lane 5:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate with RIP3 KO cells treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/5000 dilution
Predicted band size: 57 kDa
false
Exposure time: 60s
- WB
Lab
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
Blocking/Dilution buffer : 5% NFDM/TBST.
The higher MW bands in Lanes 1 and 2 are extra bands.
The lysates were prepared following the 1% SDS Hot Lysate buffer method.
For Lysate preparation protocol, please refer to the protocol section of the website and/or here.
All lanes:
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) at 1/1000 dilution
Lane 1:
Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 10 µg
Lane 2:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours at 10 µg
Lane 3:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours, then treated with alkaline phosphatase for 1 hour at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa
Observed band size: 53 kDa
false
Exposure time: 30s
- Dot
Lab
Dot Blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
Dot blot analysis of RIP3 (phospho T231 + S232) labeled with ab222320 at 1/1000 dilution.
Lane 1 : RIP3 (phospho T231 + S232) peptide (aa229-239);
Lane 2 : RIP3 (phospho T231 + S232) peptide (aa223-236);
Lane 3 : RIP3 (phospho T231) peptide (aa223-239);
Lane 4 : RIP3 (phospho S232) peptide (aa223-239);
Lane 5 : RIP3 non-phospho peptide (aa223-239).
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
- WB
CiteAb
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (AB222320)
RIP3 (phospho T231 + S232) western blot using anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] ab222320. Publication image and figure legend from Jiao, J., Wang, Y., et al., 2020, Front Pharmacol, PubMed 31998134.
ab222320 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab222320 please see the product overview.
NSA suppresses MLKL activation but not p-RIP3. Prevention of MLKL activation by treatment with 3 μM NSA for 24 h after OGD treatment. (A) NeuN and p-MLKL double staining. Cell nuclei were stained with DAPI (blue fluorescence) and neurons were stained with NeuN (red fluorescence). Pictures were taken using a fluorescence microscope (scale bar = 20 μm). (B) WB analysis of the level of p-RIP3 and p-MLKL induced by OGD, p-MLKL level was significantly reversed after NSA treatment. Data are presented as the mean ± SEM, n = 4. *p < 0.05, vs. the control group (CTL). #p < 0.05, vs. the OGD group. Data were analyzed using Student's t-test. RIP3, receptor interacting protein kinase-3; OGD, oxygen-glucose deprivation; NSA, necrosulfonamide; MLKL, mixed-lineage kinase domain-like protein; Nec-1, necrostatin-1; WB, Western blot.
false
Related conjugates and formulations (1)
-
Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Dot Blot in Mouse samples.
What is the molecular weight of RIP3?
Anti-RIP3 (phospho T231 + S232) [EPR19403-52] (ab222320) specifically detects a band for RIP3 (UniProt: Q9QZL0) at a molecular weight of 57kDa.
Trusted by the scientific community
Anti-RIP3 (phospho T231 + S232) [EPR19403-52] (ab222320) was first used in a scientific publication in 2017 and has been cited over 20 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (ab222320) has been confirmed by Western blot testing in RIP3 Knockout L-929 cell line.
Other related products
We have a range of other formats of antibody clone [EPR19403-52] also available for your convenience: ab222320, Carrier free - ab240399
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.
Pathways
RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (37)
Recent publications for all applications. Explore the full list and refine your search
Bioactive materials 53:737-753 PubMed40801020
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4288 PubMed40341069
2025
Applications
Unspecified application
Species
Unspecified reactive species
Current research in microbial sciences 7:100318 PubMed39726972
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 28:529 PubMed39290957
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 98:e0126224 PubMed39194237
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 22:355 PubMed38902678
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 181:2443-2458 PubMed38555910
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 25:2278-2305 PubMed38499808
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:663 PubMed37816709
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 9:363 PubMed37777514
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com